14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Apr 27, 2021 $127.49 $128.99 $124.00 $124.51 615 290
Apr 26, 2021 $123.04 $127.02 $122.15 $126.67 215 602
Apr 23, 2021 $123.34 $123.86 $120.10 $122.13 348 231
Apr 22, 2021 $121.70 $123.43 $119.92 $122.30 335 859
Apr 21, 2021 $120.20 $123.20 $118.42 $123.03 223 327
Apr 20, 2021 $119.44 $121.74 $118.01 $120.11 557 904
Apr 19, 2021 $121.30 $121.72 $117.81 $120.28 602 942
Apr 16, 2021 $124.34 $124.38 $121.36 $122.05 236 090
Apr 15, 2021 $123.65 $126.23 $122.90 $124.03 262 094
Apr 14, 2021 $123.39 $127.00 $122.02 $122.37 354 340
Apr 13, 2021 $123.25 $126.20 $119.76 $123.24 586 207
Apr 12, 2021 $127.28 $128.20 $122.60 $123.08 596 353
Apr 09, 2021 $129.88 $129.88 $124.95 $126.85 306 466
Apr 08, 2021 $134.19 $134.42 $128.20 $129.32 470 569
Apr 07, 2021 $139.05 $139.05 $132.64 $133.00 256 862
Apr 06, 2021 $138.63 $142.15 $138.07 $138.62 304 544
Apr 05, 2021 $139.19 $142.72 $135.06 $140.02 375 322
Apr 01, 2021 $137.23 $138.40 $132.57 $138.03 312 299
Mar 31, 2021 $133.12 $137.95 $132.66 $135.61 406 449
Mar 30, 2021 $131.44 $135.51 $130.16 $133.01 201 163
Mar 29, 2021 $135.56 $136.86 $131.18 $131.46 309 921
Mar 26, 2021 $136.09 $137.09 $132.20 $136.61 294 681
Mar 25, 2021 $131.44 $137.30 $129.84 $135.74 307 158
Mar 24, 2021 $136.67 $137.21 $130.61 $131.80 395 147
Mar 23, 2021 $139.09 $141.68 $134.86 $135.99 434 881
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT